Abstract | BACKGROUND: METHODS: We performed a retrospective analysis of patients with locally advanced or metastatic GSCC from Jan 2013 to September 2022 at Sun Yat-sen University Cancer Center. The survival and safety profiles were analyzed. RESULTS: CONCLUSIONS: Among patients with locally advanced or metastatic GSCC, immunotherapy combined with chemotherapy might be thought of as a potentially effective treatment option for patients with GSCC.
|
Authors | Riqing Huang, Meiting Chen, Haifeng Li, Xin An, Cong Xue, Anqi Hu, Ditian Shu, Wei Yang, Fangjian Zhou, Dan Sui, Kai Yao, Yonghong Li, Zhiming Wu, Zhiyong Li, Zhuowei Liu, Yanxia Shi |
Journal | BMC cancer
(BMC Cancer)
Vol. 23
Issue 1
Pg. 1002
(Oct 19 2023)
ISSN: 1471-2407 [Electronic] England |
PMID | 37858093
(Publication Type: Journal Article)
|
Copyright | © 2023. BioMed Central Ltd., part of Springer Nature. |
Topics |
- Humans
- Retrospective Studies
- Carcinoma, Small Cell
- Treatment Outcome
- Antineoplastic Combined Chemotherapy Protocols
(adverse effects)
- Immunotherapy
(adverse effects)
|